What U-100 means: the unit standard explained
The "U-100" designation on an insulin syringe is a concentration label, not a capacity label. It indicates the syringe was designed for solutions containing 100 units per milliliter. For insulin, this became the international standard after a global push toward concentration harmonization in the 1970s and 1980s. The older U-40 format, containing 40 units per milliliter, survives in some veterinary applications but is not used in research peptide protocols.
The arithmetic consequence is fixed: 1 unit on a U-100 barrel equals 0.01 mL, which equals 10 microliters. This relationship does not change regardless of what solution fills the syringe. When a researcher loads a U-100 syringe with a reconstituted BPC-157 solution from the compound catalog, the volume per unit is still 0.01 mL, the same as for insulin.
Peptide researchers use U-100 syringes not because of the insulin calibration history but because the format pairs thin-gauge needles (typically 29G to 31G) with barrels graduated for the 0.05-0.5 mL volume range that subcutaneous injection protocols typically require. No other commonly available syringe format combines needle gauge and graduation spacing as well for this application.
Three barrel sizes and their practical trade-offs
U-100 insulin syringes are produced in three barrel capacities. Each format has a different graduation pitch and a different minimum practical draw volume.
The 0.3 mL (30-unit) syringe has the smallest barrel. Its graduation marks are closely spaced, which can make reading individual units at the lower end of the scale harder than on the larger formats. This syringe suits protocols where a high reconstitution concentration results in draws of 5-20 units.
The 0.5 mL (50-unit) syringe is the most common format in peptide research. The 50 graduation marks are spread across a longer barrel than the 30-unit format, which makes each unit mark easier to read visually. For most reconstituted peptide solutions with a target draw of 10-40 units, this format is the practical first choice.
The 1.0 mL (100-unit) syringe covers the full U-100 range. It is useful when a dilute reconstitution (more bacteriostatic water added per milligram of peptide) produces a low concentration and pushes the target unit draw above 50. The graduation pitch on a 1 mL barrel is comparable to a 1 mL tuberculin syringe, though the unit labeling differs (discussed in the FAQ below).
Needle gauge and needle length are specified separately from barrel capacity. Common options for subcutaneous research use are 29G, 30G, and 31G needles in 8 mm (5/16 inch) or 12.7 mm (1/2 inch) lengths. Gauge affects draw speed through the needle but does not change the barrel graduation or the volume per unit.
The reconstitution calculation: units to micrograms
After adding bacteriostatic water to a lyophilized peptide vial, the researcher needs to know how many units on the syringe correspond to the target dose specified in the research protocol. The calculation has three inputs: total peptide mass in the vial, volume of bacteriostatic water added, and target dose per injection.
Step one: calculate concentration in micrograms per milliliter.
Example: 5 mg vial (5,000 mcg total) reconstituted with 2 mL bacteriostatic water.
5,000 mcg / 2 mL = 2,500 mcg/mL
Step two: convert concentration to micrograms per unit. Each U-100 unit equals 0.01 mL, so multiply mcg/mL by 0.01.
2,500 mcg/mL x 0.01 mL/unit = 25 mcg per unit
Step three: divide target dose by concentration per unit.
Target dose: 250 mcg
250 mcg / 25 mcg per unit = 10 units
Draw the plunger to the 10-unit mark.
Changing the bacteriostatic water volume shifts the concentration and changes the unit count proportionally. The same 5 mg vial reconstituted with 1 mL instead of 2 mL yields 5,000 mcg/mL, or 50 mcg per unit. The 250 mcg dose then requires 5 units rather than 10. Using less water increases concentration and reduces the unit draw, which moves the draw toward the low-volume end of the barrel where measurement error is higher. That accuracy trade-off is covered in the next section.
The peptide dosing calculator handles this three-step calculation directly. Enter vial size, bacteriostatic water volume, and target dose to read off the unit count without manual arithmetic.
Measurement accuracy at low volumes: what the evidence shows
U-100 insulin syringes introduce volume measurement error, and the size of that error depends on how far down the barrel the plunger sits.
A 1999 study in Diabetes Care compared U-100 insulin syringes against pen-injector devices in 48 participants drawing their own insulin doses. The absolute error when drawing doses below 5 units averaged 9.9 +/- 2.4% for syringes versus 4.9 +/- 1.6% for pen injectors. At higher unit counts, syringe accuracy improved and the gap between syringe and pen performance narrowed (Lteif and Schwenk, Diabetes Care 1999, n=48).
A 2004 study in Clinical Pediatrics dispensed 1, 2, and 5 units from multiple syringe types and devices 15 times each, weighing each delivered dose on an analytical scale. Standard U-100 syringes performed "dangerously inaccurate" at the 1-unit draw. Accuracy improved substantially by 5 units, and the gap between syringes and more precise delivery devices narrowed further at higher doses (Keith, Nicholson, and Rogers, Clinical Pediatrics 2004).
Research from sterile compounding practice gives a usable threshold. Jordan et al. (2021) evaluated accuracy and precision across five syringe capacities, measuring volumes at 5%, 10%, and 20% of each syringe's labeled capacity (n=30 draws per condition). Error rates above 5% occurred consistently when less than 20% of the labeled capacity was filled. On a 0.5 mL syringe, the 20% threshold is 10 units (0.1 mL) (Jordan et al., Hospital Pharmacy 2021).
For peptide research, this means reconstitution volume is an accuracy variable, not just a concentration variable. Adding more bacteriostatic water to a vial lowers concentration per unit, raises the unit draw count for the same dose, and keeps the draw above the 10-unit threshold on a 0.5 mL syringe. The peptide reconstitution guide covers how to select a water volume that balances concentration, stability, and measurable draw count.
Handling considerations for precise draws
Several technique factors affect measurement accuracy independent of which syringe format is selected.
Air pressure equalization: before drawing from a reconstituted vial, inject a volume of air equal to the target draw volume into the vial. This balances the pressure differential that builds up in a sealed vial as solution is withdrawn. Without equalization, the partial vacuum can cause the plunger to resist at the target mark or snap forward on needle withdrawal, pulling air into the barrel.
Bubble removal: air bubbles displace fluid volume. A 0.5-unit bubble in the barrel represents 5 microliters of solution that will not be delivered. After drawing slightly above the target mark, hold the syringe with the needle pointing upward, tap the barrel firmly to dislodge bubbles, and advance the plunger to expel the air before reading the final graduation.
Solution temperature: draw from vials at room temperature rather than cold from the refrigerator. Cold aqueous peptide solutions have slightly higher viscosity, which increases resistance during the draw and can lead to the plunger stopping short of the target mark. Removing the vial from refrigeration 5-10 minutes before drawing is adequate for most research peptide solutions.
Meniscus reading: aqueous solutions curve upward at the barrel wall, forming a concave meniscus. Read the flat center of the meniscus against the graduation mark, not the curved edge. On fine-gauge insulin barrels, this distinction is small but contributes to error at draws below 10 units.
Reconstituted peptide solutions should be stored at 2-8 degrees Celsius between uses. Storage conditions after reconstitution, including maximum storage windows, are detailed in the lyophilized peptide storage guide. Pre-loading syringes for later use is not recommended for research peptide solutions; draw immediately before each injection event.
Sourcing U-100 syringes in Bali and Indonesia
In Indonesia, insulin syringes are classified as alat kesehatan (medical devices) under BPOM (Badan Pengawas Obat dan Makanan) regulations. Standard U-100 insulin syringes from manufacturers including BD (Becton Dickinson) and Terumo are sold at licensed pharmacies (apotek) without a prescription, categorized alongside diabetes management consumables.
The 0.5 mL and 1.0 mL formats are stocked at most urban apotek in Canggu, Seminyak, Ubud, Denpasar, and Jakarta. The 0.3 mL format is less reliably available and may require a visit to a medical supply retailer (toko alat kesehatan) or an order through a medical distributor in Denpasar or a major city.
Researchers purchasing locally should confirm the barrel markings before purchase. A U-100 insulin syringe and a 1 mL tuberculin syringe look similar in packaging but use different graduation labels. The tuberculin syringe marks the barrel in milliliters and tenths; the U-100 syringe marks it in units. The volume per small graduation mark is the same (0.01 mL per mark in both cases), but purchasing a tuberculin syringe by mistake breaks the unit-based calculation workflow unless the researcher converts the target draw to milliliters first.
Storage conditions for the syringes themselves are not a significant concern at Indonesian ambient temperatures. Sealed syringe packaging is stable at the temperatures found in air-conditioned research workspaces in Bali and Java. The compound inside the vial is the temperature-sensitive component, as covered in the storage guide linked above.